VLX-2000

N/A

Report date: 2024/05/09 13:41:27
NMEFirst In Class

Base Information

Drug NameVLX-2000
Drug Alias NameVLX-2000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action12-lipoxygenase inhibitors
Targets12-lipoxygenase
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVeralox Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVeralox Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A